Open AccessNBTI 5463 Is a Novel Bacterial Type II Topoisomerase Inhibitor with Activity against Gram-Negative Bacteria and In Vivo Efficacy
Author(s) -
Thomas J. Dougherty,
Asha S. Nayar,
Joseph Newman,
Sussie Hopkins,
Gregory G. Stone,
Michele Johnstone,
Adam B. Shapiro,
Mark T.D. Cronin,
Folkert Reck,
David E. Ehmann
Publication year - 2014
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.03222-14
Subject(s) - in vivo , gram , gram negative bacteria , bacteria , gram positive bacteria , biology , topoisomerase , microbiology and biotechnology , pharmacology , escherichia coli , in vitro , biochemistry , genetics , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom